The Pilot and Feasibility Program provides support for novel diabetes-related research projects of limited scope. The goal of the program is to support exploratory research projects by new investigators (who have little or no independent research support) or established investigators who are turning to diabetes research for the first time. In the past project period 1-4 new projects have been initiated each year. In August and September there is a University-wide solicitation of proposals by electronic mail. An announcement is also placed in the VUMC newspaper. The Meharry Medical College faculty will also be alerted to the availability these awards. Proposals are reviewed by four individuals, two internal to Vanderbilt and two external to the institution and they are scored on an NIH scale. The proposals and critiques are then evaluated by the Research Advisory Committee, with the reviewers as ad hoc members, (equivalent to an NIH study section) and each proposal is assigned a priority score. The proposals and priority scores are next presented to the DRTC Executive Committee (equivalent to the NIH Council) for a funding decision. Support for a second year of research is only given when satisfactory work is completed in year one, as evaluated by a written progress report, and if external support for the project has not been obtained in the interim. The success rate of this program since it was instituted in 1978, as measured either by the number of investigators who remain involved in diabetes research (66%), or who convert their P/F study into a nationally awarded, peer reviewed grant, is high (>60%). In the past 15 years 80% of the PIs funded are still involved in diabetes related research and 76% have obtained peer reviewed funding (excluding those whose P/F projects are still active).

Project Start
2002-07-20
Project End
2003-03-31
Budget Start
Budget End
Support Year
24
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Barke, Theresa L; Goldstein, Jeffery A; Sundermann, Alexandra C et al. (2018) Gestational diabetes mellitus is associated with increased CD163 expression and iron storage in the placenta. Am J Reprod Immunol 80:e13020
Rohrbough, Jeffrey; Nguyen, Hong-Ngan; Lamb, Fred S (2018) Modulation of ClC-3 gating and proton/anion exchange by internal and external protons and the anion selectivity filter. J Physiol 596:4091-4119
Schlegel, Cameron; Lapierre, Lynne A; Weis, Victoria G et al. (2018) Reversible deficits in apical transporter trafficking associated with deficiency in diacylglycerol acyltransferase. Traffic 19:879-892
Moore, Mary Courtney; Smith, Marta S; Farmer, Ben et al. (2018) Morning Hyperinsulinemia Primes the Liver for Glucose Uptake and Glycogen Storage Later in the Day. Diabetes 67:1237-1245
Cooke, Allison L; Morris, Jamie; Melchior, John T et al. (2018) A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res 59:1244-1255
Moore, Mary Courtney; Kelley, David E; Camacho, Raul C et al. (2018) Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts. Diabetes 67:1173-1181
Funkhouser-Jones, Lisa J; van Opstal, Edward J; Sharma, Ananya et al. (2018) The Maternal Effect Gene Wds Controls Wolbachia Titer in Nasonia. Curr Biol 28:1692-1702.e6
Hart, Nathaniel J; Aramandla, Radhika; Poffenberger, Gregory et al. (2018) Cystic fibrosis-related diabetes is caused by islet loss and inflammation. JCI Insight 3:
Warren Andersen, Shaneda; Blot, William J; Shu, Xiao-Ou et al. (2018) Associations Between Neighborhood Environment, Health Behaviors, and Mortality. Am J Prev Med 54:87-95
Sui, Lina; Danzl, Nichole; Campbell, Sean R et al. (2018) ?-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells. Diabetes 67:26-35

Showing the most recent 10 out of 1487 publications